Search

Christopher R. Stone

Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1609, 1614, 1628, 4173
Total Applications
750
Issued Applications
250
Pending Applications
42
Abandoned Applications
457

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4860497 [patent_doc_number] => 20080269347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'EPINEPHRINE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 11/864234 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8531 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269347.pdf [firstpage_image] =>[orig_patent_app_number] => 11864234 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/864234
EPINEPHRINE FORMULATIONS Sep 27, 2007 Abandoned
Array ( [id] => 4834024 [patent_doc_number] => 20080132571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Nutrient Sensor' [patent_app_type] => utility [patent_app_number] => 11/862081 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12945 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132571.pdf [firstpage_image] =>[orig_patent_app_number] => 11862081 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/862081
Nutrient Sensor Sep 25, 2007 Abandoned
Array ( [id] => 4760023 [patent_doc_number] => 20080312249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'KMUP-1 CAPABLE OF TREATING HYPERTENSION' [patent_app_type] => utility [patent_app_number] => 11/857483 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 3786 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312249.pdf [firstpage_image] =>[orig_patent_app_number] => 11857483 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/857483
KMUP-1 CAPABLE OF TREATING HYPERTENSION Sep 18, 2007 Abandoned
Array ( [id] => 5474423 [patent_doc_number] => 20090247589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Monocarboxylates for modifying macrophage function' [patent_app_type] => utility [patent_app_number] => 12/310971 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3368 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247589.pdf [firstpage_image] =>[orig_patent_app_number] => 12310971 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/310971
Monocarboxylates for modifying macrophage function Sep 11, 2007 Abandoned
Array ( [id] => 8398436 [patent_doc_number] => 08268817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Substituted oxazole ketone modulators of fatty acid amide hydrolase' [patent_app_type] => utility [patent_app_number] => 12/310747 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18263 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310747 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/310747
Substituted oxazole ketone modulators of fatty acid amide hydrolase Sep 6, 2007 Issued
Array ( [id] => 6613253 [patent_doc_number] => 20100310455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Heterocyclic Ligands for Integrin Imaging and Therapy' [patent_app_type] => utility [patent_app_number] => 12/440219 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19288 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310455.pdf [firstpage_image] =>[orig_patent_app_number] => 12440219 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/440219
Heterocyclic ligands for integrin imaging and therapy Sep 6, 2007 Issued
Array ( [id] => 7535245 [patent_doc_number] => 08048871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Compositions and methods for inhibiting cytochrome P450' [patent_app_type] => utility [patent_app_number] => 11/841157 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 1 [patent_no_of_words] => 18919 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048871.pdf [firstpage_image] =>[orig_patent_app_number] => 11841157 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/841157
Compositions and methods for inhibiting cytochrome P450 Aug 19, 2007 Issued
Array ( [id] => 8063523 [patent_doc_number] => 20110245262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/310299 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40092 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245262.pdf [firstpage_image] =>[orig_patent_app_number] => 12310299 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/310299
Compounds for treating proliferative disorders Aug 19, 2007 Issued
Array ( [id] => 5465778 [patent_doc_number] => 20090325978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'STABLE LYOPHILIZED PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/375132 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9844 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325978.pdf [firstpage_image] =>[orig_patent_app_number] => 12375132 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375132
STABLE LYOPHILIZED PREPARATION Aug 12, 2007 Abandoned
Array ( [id] => 6583900 [patent_doc_number] => 20100291236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'OSMIUM COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/377051 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17730 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291236.pdf [firstpage_image] =>[orig_patent_app_number] => 12377051 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/377051
OSMIUM COMPOUNDS Aug 9, 2007 Abandoned
Array ( [id] => 6432007 [patent_doc_number] => 20100152180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => '4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)' [patent_app_type] => utility [patent_app_number] => 12/376613 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21933 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152180.pdf [firstpage_image] =>[orig_patent_app_number] => 12376613 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/376613
4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) Aug 5, 2007 Abandoned
Array ( [id] => 4734430 [patent_doc_number] => 20080051410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Protein Kinase Targeted Therapeutics' [patent_app_type] => utility [patent_app_number] => 11/833152 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8562 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051410.pdf [firstpage_image] =>[orig_patent_app_number] => 11833152 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/833152
Protein Kinase Targeted Therapeutics Aug 1, 2007 Abandoned
Array ( [id] => 6596554 [patent_doc_number] => 20100048609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID' [patent_app_type] => utility [patent_app_number] => 12/376118 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7633 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048609.pdf [firstpage_image] =>[orig_patent_app_number] => 12376118 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/376118
PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID Jul 31, 2007 Abandoned
Array ( [id] => 4687673 [patent_doc_number] => 20080031854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'THIOLATED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF' [patent_app_type] => utility [patent_app_number] => 11/776519 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14489 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031854.pdf [firstpage_image] =>[orig_patent_app_number] => 11776519 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/776519
THIOLATED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF Jul 10, 2007 Abandoned
Array ( [id] => 4887685 [patent_doc_number] => 20080262017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Sugar-Free Storage-Stable Antihistaminic Syrups' [patent_app_type] => utility [patent_app_number] => 11/769351 [patent_app_country] => US [patent_app_date] => 2007-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5268 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262017.pdf [firstpage_image] =>[orig_patent_app_number] => 11769351 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/769351
Sugar-Free Storage-Stable Antihistaminic Syrups Jun 26, 2007 Abandoned
Array ( [id] => 4916299 [patent_doc_number] => 20080096900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Methods for treating atherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/823251 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24586 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096900.pdf [firstpage_image] =>[orig_patent_app_number] => 11823251 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/823251
Methods for treating atherosclerosis Jun 25, 2007 Abandoned
Array ( [id] => 6568857 [patent_doc_number] => 20100234399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'AGENT FOR OVERCOMING RESISTANCE TO ANTI-CANCER AGENT' [patent_app_type] => utility [patent_app_number] => 12/305809 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5023 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234399.pdf [firstpage_image] =>[orig_patent_app_number] => 12305809 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/305809
AGENT FOR OVERCOMING RESISTANCE TO ANTI-CANCER AGENT Jun 21, 2007 Abandoned
Array ( [id] => 5398432 [patent_doc_number] => 20090318495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'ETHENYL CARBOXAMIDE DERIVATIVES USEFUL AS MICROBIOCIDES' [patent_app_type] => utility [patent_app_number] => 12/304177 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19587 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318495.pdf [firstpage_image] =>[orig_patent_app_number] => 12304177 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/304177
Ethenyl carboxamide derivatives useful as microbiocides Jun 13, 2007 Issued
Array ( [id] => 4670530 [patent_doc_number] => 20080045590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR PRODUCING DRUGS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME' [patent_app_type] => utility [patent_app_number] => 11/759510 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12846 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045590.pdf [firstpage_image] =>[orig_patent_app_number] => 11759510 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/759510
USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR PRODUCING DRUGS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME Jun 6, 2007 Abandoned
Array ( [id] => 5490078 [patent_doc_number] => 20090291149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Method for treatment of overfiltering and leaking blebs with sterile talc' [patent_app_type] => utility [patent_app_number] => 12/308098 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291149.pdf [firstpage_image] =>[orig_patent_app_number] => 12308098 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/308098
Method for treatment of overfiltering and leaking blebs with sterile talc Jun 6, 2007 Abandoned
Menu